Cipla's HIV Drug Gets FDA Approval

by Medindia Content Team on  June 26, 2006 at 9:53 AM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Cipla's HIV Drug Gets FDA Approval
Pharma giant Cipla has received the approval from the Food and Drug Administration for its "abbreviated new drug application (ANDA) for anti-HIV/AIDS drug Slamivudine," according to a posting on the FDA site.

The website reported that the tentative approval for ANDA is for an oral solution with strength of 10mg per ml. The new drug belongs to a class of drugs called as nucleoside reverse transcriptase inhibitors. It stops the replication of the HIV virus and hepatitis B virus as well.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
guest

Indian companies lead by Cipla are doing a great service to the mankind by supplying Generice drugs to many countries under WHO and Clinton foundation.

Indian companies lead by Cipla are doing a great service to the mankind by supplying Generice drugs to many countries under WHO and Clinton foundation.

guest

Cipla has done a great service to patients suffering from AIDS; even Bill Clinton acknowledged it when he visited their factory.

More News on:

Oral Health And AIDS Drug Toxicity AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive